Metin Kurtoglu Selecta Biosciences Inc (SELB) insider trading activity

SELB Quotes by TradingView

Metin Kurtoglu is Chief Technology Officer of SELECTA BIOSCIENCES INC. Currently has a direct ownership of 62,258 shares of SELB, which is worth approximately $52,296. The most recent transaction as insider was on Jan 06, 2025, when has been sold 2,458 shares (Common Stock) at a price of $16.83 per share, resulting in proceeds of $41,368. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.3K
95.93% 3M change
95.93% 12M change
Total Value Held $52,296

Metin Kurtoglu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2025
SELL
Open market or private sale
$41,368 $16.83 p/Share
2,458 Reduced 3.8%
62,258 Common Stock
Jan 03 2025
SELL
Open market or private sale
$40,412 $16.72 p/Share
2,417 Reduced 3.6%
64,716 Common Stock
Jan 02 2025
BUY
Grant, award, or other acquisition
-
16,100 Added 19.34%
67,133 Common Stock
Dec 10 2024
SELL
Open market or private sale
$70,639 $24.35 p/Share
2,901 Reduced 5.38%
51,033 Common Stock
Dec 10 2024
BUY
Exercise of conversion of derivative security
$4,090 $1.41 p/Share
2,901 Added 5.1%
53,934 Common Stock
Dec 09 2024
SELL
Open market or private sale
$274,994 $25.55 p/Share
10,763 Reduced 17.42%
51,033 Common Stock
Dec 09 2024
BUY
Exercise of conversion of derivative security
$15,175 $1.41 p/Share
10,763 Added 14.83%
61,796 Common Stock
Nov 21 2024
SELL
Open market or private sale
$546,592 $16.67 p/Share
32,789 Reduced 39.12%
51,033 Common Stock
Nov 21 2024
BUY
Exercise of conversion of derivative security
$46,232 $1.41 p/Share
32,789 Added 28.12%
83,822 Common Stock
Nov 20 2024
SELL
Open market or private sale
$100,833 $17.69 p/Share
5,700 Reduced 10.05%
51,033 Common Stock
Nov 20 2024
BUY
Exercise of conversion of derivative security
$8,036 $1.41 p/Share
5,700 Added 9.13%
56,733 Common Stock
Nov 19 2024
SELL
Open market or private sale
$3,900 $19.5 p/Share
200 Reduced 0.39%
51,033 Common Stock
Nov 19 2024
BUY
Exercise of conversion of derivative security
$282 $1.41 p/Share
200 Added 0.39%
51,233 Common Stock
Nov 18 2024
SELL
Open market or private sale
$632,616 $18.39 p/Share
34,400 Reduced 40.27%
51,033 Common Stock
Nov 18 2024
BUY
Exercise of conversion of derivative security
$48,504 $1.41 p/Share
34,400 Added 28.71%
85,433 Common Stock
Nov 15 2024
SELL
Open market or private sale
$379,569 $17.2 p/Share
22,068 Reduced 30.19%
51,033 Common Stock
Nov 15 2024
BUY
Exercise of conversion of derivative security
$31,115 $1.41 p/Share
22,068 Added 23.19%
73,101 Common Stock
Nov 14 2024
SELL
Open market or private sale
$432,530 $16.7 p/Share
25,900 Reduced 33.67%
51,033 Common Stock
Nov 14 2024
BUY
Exercise of conversion of derivative security
$36,519 $1.41 p/Share
25,900 Added 25.19%
76,933 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
1,531,000 Added 50.0%
1,531,000 Common Stock
MK

Metin Kurtoglu

Chief Technology Officer
Watertown, MA

Track Institutional and Insider Activities on SELB

Follow SELECTA BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SELB shares.

Notify only if

Insider Trading

Get notified when an Selecta Biosciences Inc insider buys or sells SELB shares.

Notify only if

News

Receive news related to SELECTA BIOSCIENCES INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SELB